NCT06950372View on ClinicalTrials.gov

Ropivacaine Concentration and Rebound Pain

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Radius Fracture DistalRebound Pain
Interventions
DRUG

Ropivacaine concentration low

Brachial plexus nerve block with ropivacaine 3.75 mg/ml

DRUG

Ropivacaine concentration high

Brachial plexus nerve block with ropivacaine 7.5 mg/ml

Trial Locations (1)

Unknown

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Oslo University Hospital

OTHER

NCT06950372 - Ropivacaine Concentration and Rebound Pain | Biotech Hunter | Biotech Hunter